Tumor-Derived Prostaglandin E2 Promotes p50 NF-kappaB-Dependent Differentiation of Monocytic MDSCs. Porta C, Consonni FM, Morlacchi S, Sangaletti S, et al. Cancer Res 2020;80:2874-2888.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Porta C, Consonni FM, Morlacchi S, Sangaletti S, et al. Tumor-Derived Prostaglandin E2 Promotes p50 NF-kappaB-Dependent Differentiation of Monocytic MDSCs. Cancer Res 2020;80:2874-2888.
PMID: 32265223